Results 31 to 40 of about 86,041 (135)

Safety and efficacy of the sulfydryl ACE-inhibitor zofenopril in the management of cardiovascular disease

Кардиоваскулярная терапия и профилактика, 2011
In the 1970s, pharmacological therapy interrupting the renin-angiotensin system was considered beneficial for patients with high-renin hypertension. Angiotensin-converting enzyme (ACE) inhibitors proved to be effective not only in patients with high ...
C. Napoli
doaj   +1 more source

New perspectives in the renin-angiotensin-aldosterone system (RAAS) I: endogenous angiotensin converting enzyme (ACE) inhibition.

PLoS ONE, 2014
Angiotensin-converting enzyme (ACE) inhibitors represent the fifth most often prescribed drugs. ACE inhibitors decrease 5-year mortality by approximately one-fifth in cardiovascular patients. Surprisingly, there are reports dating back to 1979 suggesting
Miklós Fagyas, Katalin Úri, Ivetta M Siket, Andrea Daragó, Judit Boczán, Emese Bányai, István Édes, Zoltán Papp, Attila Tóth   +8 more
doaj   +1 more source

TO THE 110-TH ANNIVERSARY OF RENIN FINDING. FIGHT OF TITANS: ANGIOTENSIN CONVERTING ENZYME INHIBITORS AND SARTANS

Рациональная фармакотерапия в кардиологии, 2016
Angiotensin converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARB) slow down progression of cardiovascular diseases and reduce risk of mortality and life threatening complications.
L. N. Malay, A. N. Miroshnichenko, B. V. Sharykin, V. V. Konurovsky   +3 more
doaj   +3 more sources

Multilevel analysis of systolic blood pressure and ACE gene I/D polymorphism in 438 Swedish families – a public health perspective

BMC Medical Genetics, 2006
Background Individuals belonging to the same family share a number of genetic as well as environmental circumstances that may condition a common SBP level.
Råstam Lennart, Lindblad Ulf, Bengtsson-Boström Kristina, Merlo Juan, Melander Olle   +4 more
doaj   +1 more source

An Angiotensin-converting Enzyme Inhibition Activity by Various Natural Approaches: A Statistic Review

Archives of Medicine and Health Sciences
The most prevalent cardiovascular illness in the world, hypertension, is a significant public health issue in both developed and developing nations. A major risk of cardiovascular disease and high blood pressure is morbidity and mortality.
Rupal K. Chhaniyara, Dhara A. Gamit
doaj   +1 more source

New perspectives in the renin-angiotensin-aldosterone system (RAAS) III: endogenous inhibition of angiotensin converting enzyme (ACE) provides protection against cardiovascular diseases.

PLoS ONE, 2014
ACE inhibitor drugs decrease mortality by up to one-fifth in cardiovascular patients. Surprisingly, there are reports dating back to 1979 suggesting the existence of endogenous ACE inhibitors.
Miklós Fagyas, Katalin Úri, Ivetta M Siket, Andrea Daragó, Judit Boczán, Emese Bányai, István Édes, Zoltán Papp, Attila Tóth   +8 more
doaj   +1 more source

ACE inhibitors in patients with acute myocardial infarction

Кардиоваскулярная терапия и профилактика, 2005
The article is devoted to modern perspectives of ACE inhibitor therapy in patients with acute myocardial infarction (AMI). ACE inhibitor efficacy is analyzed, according to the results of large randomized studies.
S. N. Tereshchenko, N. A. Dzhaiani
doaj  

Incidence of adverse events with telmisartan compared with ACE inhibitors: evidence from a pooled analysis of clinical trials

Patient Preference and Adherence, 2011
Giuseppe Mancia1, Helmut Schumacher21Universita degli Studi Milano-Bicocca, Ospedale San Gerardo di Monza, Milan, Italy; 2Boehringer Ingelheim Pharma GmbH and Co KG, Ingelheim, GermanyAbstract: Telmisartan is indicated for the prevention of ...
Mancia G, Schumacher H
doaj  

Epidemiology of cardioprotective pharmacological agent use in stable coronary heart disease

Indian Heart Journal, 2013
Objective: To determine use of class and type of cardioprotective pharmacological agents in patients with stable coronary heart disease (CHD) we performed a prescription audit.
Krishna Kumar Sharma, Mukul Mathur, Rakesh Gupta, Soneil Guptha, Sanjeeb Roy, R.S. Khedar, Nishant Gupta, Rajeev Gupta   +7 more
doaj   +1 more source

EVIDENCE-BASED CHOICE OF ACE INHIBITORS

Российский кардиологический журнал, 2012
Angiotensin-converting enzyme (ACE) inhibitors are currently one of the most frequently used groups of cardiovascular medications. In addition to wellknown indications, such as arterial hypertension (AH), chronic heart failure (CHF), and Type 2 diabetes ...
G. E. Gendlin, O. A. Miller, A. V. Melekhov   +2 more
doaj